Senior insider sale
EVP & Chief Financial Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$1.16M
110.19K shares
O'BYRNE JASON plans to sell 110.19K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $1.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
ESPP Purchase
Cash
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/29/2026 | ESPP Purchase Cash | 492.00 | — |
2/24/2026 | Restricted Stock Vesting Compensation | 3.37K | — |
2/23/2026 | Restricted Stock Vesting Compensation | 2.91K | — |
11/28/2025 | Restricted Stock Vesting Compensation | 637.00 | — |
11/15/2025 | Restricted Stock Vesting Compensation | 11.95K | — |
| Total | 19.36K | ||
Completed
Units to sell
28.33K
Market value
$315.2K
Units to sell
23.15K
Market value
$242.6K
Units to sell
14.35K
Market value
$142.1K
Units to sell
25K
Market value
$245.3K
Planned — Approximate Date
Units to sell
19.36K
Market value
$212.9K
Units
110.19K
Value
$1.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2026 | 28.33K | $315.2K | — | Completed |
8/25/2026 | 23.15K | $242.6K | — | Completed |
8/24/2026 | 14.35K | $142.1K | — | Completed |
8/21/2026 | 25K | $245.3K | — | Completed |
| Planned — Approximate Date | ||||
9/17/2026 | 19.36K | $212.9K | NASDAQ | Planned |
| Total | 110.19K | $1.16M | ||